5 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Treatment of with Community-Acquired ... Pneumonia (CAP) ... #Community #Acquired ... #Pneumonia #Antibiotics ... Management #Guidelines #pharmacology
Aminoglycosides  - Antibiotics Class Overview

Gentamicin, Tobramycin, Amikacin, Streptomycin -30S inhibitor (all IV)
Spectrum: Extremely efficacious vs.
Aminoglycosides - Antibiotics ... Gentamicin, Tobramycin, Amikacin ... is suspected (pneumonia ... #Pharmacology #Antibiotics ... #Review #Overview
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Severe cryptococcal pneumonia ... #Pharmacology #Antibiotics ... #Review #Overview ... #Flutycosine #Antifungal
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... pneumonia, sinusitis ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics ... #Review #Overview
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Anti-Pseudomonal - Antibiotics ... /VAP, catheter-related ... – On average, Amikacin ... Polymyxin B(IV) #Pharmacology ... #Antibiotics #Review